LIVN LivaNova
WatchlistAbout LivaNova Company
LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the Cardiopulmonary and Other segments. The Cardiopulmonary segment is involved in the development, production and sale of cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, and related accessories. The Other segment includes heart valves business and corporate shared service expenses for finance, legal, human resources, information technology, and corporate business development. The company was founded in 1987 and is headquartered in London, the United Kingdom.
Company Profile
Company Executives
- Name
- Position
- Salary
- William A. Kozy
- Chairman of the Board and Interim Chief Executive Officer
- 389.99K
- Michael David Hutchinson
- Senior Vice President, Chief Legal Officer and Corporate Secretary
- --
- Trui Hebbelinck
- Chief Human Resources Officer
- 1.69M
- Alex Shvartsburg
- Chief Financial Officer and Principal Accounting Officer
- 2.13M
- Marco Dolci
- President, Cardiopulmonary Business Unit
- 2.21M
- James Christopher Barry
- Director
- --
- Daniel Jeffrey Moore
- Independent Director
- 247.06K
- Peter M. Wilver
- Independent Director
- 203.04K
- Todd C. Schermerhorn
- Independent Director
- 269.96K
- Stacy Enxing Seng
- Independent Director
- 259.96K
- Dr. Sharon O'Kane
- Lead Independent Director
- 257.71K
- Francesco Bianchi
- Independent Director
- 262.96K
- Andrea L. Saia
- Independent Director
- 262.06K
- David S. Wise
- Senior Advisor
- --
- Brooke Story
- Independent Director
- 130.76K